Absent T Lymphocytes

Search Trials
Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation
Status:
Recruiting
Last Changed:
Jan 28, 2022
First Changed:
Nov 27, 2019
Disease(s):
Haematologic Disease
Intervention(s):
CTL 19
A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
Status:
Recruiting
Last Changed:
May 17, 2022
First Changed:
Sep 29, 2020
Disease(s):
Peripheral T-cell Lymphoma
Intervention(s):
brentuximab vedotincyclophosphamidedoxorubicinprednisone
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
Status:
Recruiting
Last Changed:
Apr 13, 2022
First Changed:
Nov 8, 2016
Disease(s):
Breast Adenocarcinoma
Intervention(s):
DoxorubicinCyclophosphamidePaclitaxelCarboplatinDecitabinePembrolizumab
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
Status:
Unknown status
Last Changed:
Dec 5, 2016
First Changed:
Oct 27, 2015
Disease(s):
Hepatocellular Carcinoma
Intervention(s):
anti-MUC1 CAR T Cells
Calaspargase Pegol in Adults With ALL
Status:
Recruiting
Last Changed:
Apr 26, 2022
First Changed:
Mar 26, 2021
Disease(s):
Acute Lymphoblastic Leukemia
Intervention(s):
Calaspargase pegol (S95015)

Connect. Empower. Inspire.